Wang H, Han J, Kong H, Ma C, Zhang X
Biomolecules. 2025; 15(2).
PMID: 40001550
PMC: 11853213.
DOI: 10.3390/biom15020247.
Bi F, Gao C, Guo H
FASEB Bioadv. 2024; 6(11):477-502.
PMID: 39512842
PMC: 11539034.
DOI: 10.1096/fba.2024-00080.
Wang T, Zhang L, Gao W, Liu Y, Yue F, Ma X
BMC Med Genomics. 2024; 17(1):251.
PMID: 39394578
PMC: 11470675.
DOI: 10.1186/s12920-024-02013-3.
Tang H, Du Y, Tan Z, Li D, Xie J
J Orthop Translat. 2024; 48:190-203.
PMID: 39280633
PMC: 11393600.
DOI: 10.1016/j.jot.2024.08.008.
Wang K, Wang Y, Li Y, Fang B, Li B, Cheng W
iScience. 2024; 27(8):110524.
PMID: 39165846
PMC: 11334793.
DOI: 10.1016/j.isci.2024.110524.
Long Non-coding RNA DNM3OS: Pathogenic Roles and Molecular Mechanisms in Pathophysiological Processes.
Wang S, Hu Y, Wang R, Zhang Y, Yuan Q, Yuan C
Curr Med Chem. 2024; 31(29):4687-4702.
PMID: 39081025
DOI: 10.2174/0109298673280484240101070607.
The mA-ncRNAs axis in diabetes complications: novel mechanism and therapeutic potential.
Yu S, Li C, Lu X, Han Z, Li Y, Yuan X
Front Endocrinol (Lausanne). 2024; 15:1426380.
PMID: 38978623
PMC: 11228181.
DOI: 10.3389/fendo.2024.1426380.
RNA mA modification regulates cell fate transition between pluripotent stem cells and 2-cell-like cells.
Su Z, Dong Y, Sun J, Wu Y, Wei Q, Liang Y
Cell Prolif. 2024; 57(9):e13696.
PMID: 38952035
PMC: 11503247.
DOI: 10.1111/cpr.13696.
An Overview of Current Detection Methods for RNA Methylation.
Saglam B, Akgul B
Int J Mol Sci. 2024; 25(6).
PMID: 38542072
PMC: 10970374.
DOI: 10.3390/ijms25063098.
HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.
Ma Q, Ye S, Liu H, Zhao Y, Mao Y, Zhang W
Front Oncol. 2024; 14:1320887.
PMID: 38361784
PMC: 10867147.
DOI: 10.3389/fonc.2024.1320887.
CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine.
Chanchal D, Chaudhary J, Kumar P, Agnihotri N, Porwal P
Curr Gene Ther. 2024; 24(3):193-207.
PMID: 38310456
DOI: 10.2174/0115665232275754231204072320.
Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.
Yang S, Li K, Zhang J, Liu J, Liu L, Tan Y
Exp Biol Med (Maywood). 2024; 248(23):2273-2288.
PMID: 38166412
PMC: 10903232.
DOI: 10.1177/15353702231214266.
Intron Editing Reveals -Dependent Maturation of the Small Nucleolar RNA Host Gene in Human Cells.
Matveeva A, Vinogradov D, Zhuravlev E, Semenov D, Vlassov V, Stepanov G
Int J Mol Sci. 2023; 24(24).
PMID: 38139448
PMC: 10743478.
DOI: 10.3390/ijms242417621.
New understandings of the genetic regulatory relationship between non-coding RNAs and mA modification.
Liu S, Xiang D
Front Genet. 2023; 14:1270983.
PMID: 38125749
PMC: 10731383.
DOI: 10.3389/fgene.2023.1270983.
N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y, Xu Y, Bao Y, Luo Y, Qiu G, He M
Epigenetics. 2023; 18(1):2260213.
PMID: 37766615
PMC: 10540650.
DOI: 10.1080/15592294.2023.2260213.
Synapse-Enriched mA-Modified Malat1 Interacts with the Novel mA Reader, DPYSL2, and Is Required for Fear-Extinction Memory.
Madugalle S, Liau W, Zhao Q, Li X, Gong H, Marshall P
J Neurosci. 2023; 43(43):7084-7100.
PMID: 37669863
PMC: 10601377.
DOI: 10.1523/JNEUROSCI.0943-23.2023.
Epigenetic alterations and advancement of lymphoma treatment.
Zhuang S, Yang Z, Cui Z, Zhang Y, Che F
Ann Hematol. 2023; 103(5):1435-1454.
PMID: 37581713
DOI: 10.1007/s00277-023-05395-z.
M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression.
Liang E, Xiao S, Zhao C, Zhang Y, Fu G
Heliyon. 2023; 9(6):e16905.
PMID: 37332938
PMC: 10275791.
DOI: 10.1016/j.heliyon.2023.e16905.
CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through mA-dependent manner.
Qi F, Shen W, Wei X, Cheng Y, Xu F, Zheng Y
Cell Mol Life Sci. 2023; 80(6):156.
PMID: 37208565
PMC: 11072693.
DOI: 10.1007/s00018-023-04798-5.
An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q
Cancer Cell Int. 2023; 23(1):85.
PMID: 37158958
PMC: 10165842.
DOI: 10.1186/s12935-023-02933-7.